Brief: Xspray Reports Loss Before Tax of SEK 34.827 Million
04/05/2023 07:22
May 4 (Reuters) - Xspray Q1 revenue SEK 0. * Q1 pretax profit SEK -34.827 million * Q1 adjusted EPS SEK -1.54 * Q1 adjusted free cash flow SEK -45.535 million
Recent news on Xspray Pharma publ AB
See all newsBrief: Xspray Pharma Gets CRL From FDA
Sweden's Xspray Q1 loss narrows, upbeat on Dasynoc prospects
Brief: Xspray Pharma Q1 Pretax Loss SEK 35.4 Mln
Brief: Xspray Pharma To Receive About SEK 113 Million From Rights, Over-Allotment Issues
Brief: FDA Accepts Trade Name Nilopki For Xspray's Drug Candidate XS003